Episode Details

Back to Episodes
Does ANKTIVA's New Trial Data Add Up? — Let’s Look Closely!

Does ANKTIVA's New Trial Data Add Up? — Let’s Look Closely!

Season 1 Episode 49 Published 2 months, 1 week ago
Description

Send us Fan Mail

We analyze ImmunityBio’s (ANKTIVA) new trial data to see whether the results actually support the claims.

👉 Get your free guide, '10 Things to Elevate Your Chemo Journey'

👉 Want personalized attention to help you along your individual cancer journey? Explore 1:1 sessions with Dr. Chaplin

👉 Want to find out more about Dr. Chaplin's journey of bringing a cancer drug to market? Explore his innovations

--------------------------------------------

Episode Description: 

Every January, biotech companies flood the news cycle with bold claims, exciting headlines, and promises of cancer treatment breakthroughs. And at first glance, some of them sound incredible.  But when you look closely at the actual data, the story can change — sometimes dramatically.  In our newest blog post, Dr. Jay Chaplin breaks down the latest ImmunityBio updates, including for Anktiva, and explains why these clinical trial results deserve a much closer look. Not because the science lacks potential — quite the opposite — but because how a drug is tested and reported matters just as much as what it’s designed to do. 
This post walks through:
    • Why small trial sizes distort cancer immunotherapy results
    • How missing control groups make it impossible to know what’s really working
    • Why immune cell expansion doesn’t automatically mean tumor control
    • How hype-driven reporting can delay real progress for cancer patients
If you or someone you love is navigating cancer treatment, understanding how to separate solid science from marketing language is essential. This isn’t about tearing down innovation — it’s about protecting patients from confusion, false hope, and wasted time.

--------------------------------------------

Inquiries: 

info@elevatingcancertreatment.com

https://elevatingcancertreatment.com

--------------------------------------------

Disclaimer:
The information provided in this podcast is for educational and informational purposes only, and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have heard or read in this podcast or on this channel.
Reliance on any information provided by Dr. Jay Chaplin or Elevating Cancer Treatment is solely at your own risk. Dr. Jay Chaplin is a scientist and drug developer, not a medical doctor providing patient care. The content presented here reflects general scientific understanding and research, and may not be applicable to your individual health circumstances. Individual medical conditions and treatments vary, and no two situations are exactly alike.
Always consult with your personal healthcare provider before making any decisions about your health or treatment plan.


Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us